Juan Leal has over 15 years of working experience in pharmaceutical and biotechnological drug development companies, a highly FDA-regulated environment. He has over 15 years of experience in designing, developing and conducting animal studies or clinical trials of new drug products in development.

He has also been a participating team member of 20+ drug development programs, from which 5 drug products were successfully launched, and has supervised 25+ scientists and research assistants. He has also led the design, implementation and evaluation of the clinical biomarkers strategy of five clinical development programs and led the design of in vitro and in vivo models, its validation, and application to evaluate the safety and efficacy of new molecular entities and selection of new drug candidates for clinical development.